Journal of Neuroscience Research · 2014 · 18 citations · 104 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyNeurologic PharmacotherapyNeuropharmacologyNeuroprotectionSpinal Cord InjuryFunctional Outcome EvaluationFunctional Outcome MeasurementNeuroprotection In Spinal TraumaSpinal Cord Injury ModelsSpinal Cord Injury NeuroprotectionSpinal Cord Injury PathophysiologySpinal Cord Injury RecoverySpinal Cord Injury Repair
Because of the complex, multifaceted nature of spinal cord injury (SCI), it is widely believed that a combination of approaches will be superior to individual treatments. Therefore, we employed a rat model of cervical SCI to evaluate the combination of four noninvasive treatments that individually have been reported to be effective for acute SCI during clinically relevant therapeutic time windows. These treatments included ghrelin, ibuprofen, C16, and ketogenic diet (KD). These were selected not only because of their previously reported efficacy in SCI models but also for their potentially different mechanisms of action. The administration of ghrelin, ibuprofen, C16, and KD several hours to days postinjury was based on previous observations by others that each treatment had profound effects on the pathophysiology and functional outcome following SCI. Here we showed that, with the exception of a modest improvement in performance on the Montoya staircase test at 8-10 weeks postinjury, the combinatorial treatment with ghrelin, ibuprofen, C16, and KD did not result in any significant improvements in the rearing test, grooming test, or horizontal ladder. Histologic analysis of the spinal cords did not reveal any significant differences in tissue sparing between treatment and control groups. Although single approaches of ghrelin, ibuprofen, C16, and KD have been reported to be beneficial after SCI, our results show that the combination of the four interventions did not confer significant functional or histological improvements in a cervical model of SCI. Possible interactions among the treatments may have negated their beneficial effects, emphasizing the challenges that have to be addressed when considering combinatorial drug therapies for SCI.
104
Kristina A. Kigerl, John C. Gensel, Daniel P. Ankeny et al. · Journal of Neuroscience · 2009 · 2.2K citations · Full text
Medicine, Neurobiology, Neuroscience +17
Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR Pathway
Kevin K. Park, Kai Liu, Yang Hu et al. · Science · 2008 · 1.7K citations · Full text
Medicine, Neurobiology, Neuroscience +16
PTEN deletion enhances the regenerative ability of adult corticospinal neurons
Kai Liu, Yi Lu, Jae K. Lee et al. · Nature Neuroscience · 2010 · 990 citations · Full text
The cellular inflammatory response in human spinal cords after injury
Judith C. Fleming, M. D. Norenberg, David A. Ramsay et al. · Brain · 2006 · 863 citations · Full text